Bixiye
P52-17 New Drug-Related Prior Authorization with Quantity Limit Criteria: Parathyroid Hormone Analog for Osteoporosis
Taariikhda uu dhaqangalayo barnaamijka: Okt 03, 2017
Natiijooyinka Raadinta
Soo bandhiga 3101 - 3110 ee natiijooyinka 4130
Bixiye
P9-17 A New Drug, Ingrezza (valbenazine) Will Require Prior Authorization
Taariikhda uu dhaqangalayo Barnaamijka: Mar 21, 2017
Bixiye
P48-17 EquiClaim to Perform Focused and Limited Hospital Bill Validation Services
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 19, 2017
Bixiye
P21-17 New Drug-Related Prior Authorization with Quantity Limit for Entresto
Taariikhda uu dhaqangalayo Barnaamijka: May 08, 2017
Bixiye
P45-17 New Drug-Related Prior Authorization and Quantity Limit Criteria: Concurrent Opioids with Buprenorphine
Taariikhda barnaamijka Dhaqangalayso Agosto 14, 2017
Bixiye
P13-17 Added Reimbursement Policy for General Coding: Total Parenteral Nutrition Billing
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 07, 2017
Bixiye
P42-17 Addition of Drugs to Self-Administered Oncology Prior Authorization with Quantity Limit Program
Taariikhda barnaamijka Dhaqangalayso Agosto 03, 2017
Bixiye
P77-17 Medicare Advantage Process for NOMNC Letter
Taariikhda uu dhaqangalayo Barnaamijka: Des 12, 2017
Bixiye
P44-17 New Drug-Related Prior Authorization and Quantity Limit Criteria: Opioid, Buprenorphine Concurrent Therapy
Taariikhda barnaamijka Dhaqangalayso Agosto 14, 2017
Bixiye
P16-17 Changes in Medical Policy IV-107 Hip Arthroplasty (Hip Replacement) and Hip Resurfacing
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 28, 2017